| Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder (NCT00380692) | Eli Lilly and Company | 2006-10-01 |
| Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder (NCT00381407) | NYU Langone Health | 2006-09-01 |
| Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD) (NCT00328224) | Hadassah Medical Organization | 2006-05-01 |
| Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00320528) | Eli Lilly and Company | 2006-04-01 |
| Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder (NCT00316290) | University of Maryland, College Park | 2006-04-01 |
| A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder (NCT00326391) | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 2006-04-01 |
| The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (NCT00773916) | Federal University of Rio Grande do Sul | 2006-03-01 |
| Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder (NCT00429221) | New York State Psychiatric Institute | 2006-01-01 |
| Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse (NCT00248092) | New River Pharmaceuticals | 2006-01-01 |
| Atomoxetine Treatment for ADHD and Marijuana Dependence (NCT00360269) | Medical University of South Carolina | 2005-11-01 |
| Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) (NCT00757029) | Hallym University Medical Center | 2005-10-01 |
| Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder (NCT00142961) | New York State Psychiatric Institute | 2005-10-01 |
| Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children (NCT00254462) | University of Nebraska | 2005-10-01 |
| Safety and Efficacy of SPD465 in Adults With ADHD (NCT00202605) | Shire | 2005-09-29 |
| Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories (NCT00247572) | New River Pharmaceuticals | 2005-09-01 |
| Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children (NCT00178503) | The University of Texas Health Science Center, Houston | 2005-09-01 |
| Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children (NCT00183391) | Icahn School of Medicine at Mount Sinai | 2005-07-01 |
| School-Based Mental Health Services for Urban Children (NCT00612690) | University of Illinois at Chicago | 2005-06-01 |
| Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy (NCT00151983) | Noven Therapeutics | 2005-06-01 |
| Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD (NCT00151970) | Noven Therapeutics | 2005-06-01 |
| Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 (NCT00150592) | Shire | 2005-05-12 |
| Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults (NCT00278473) | Icahn School of Medicine at Mount Sinai | 2005-05-01 |
| Safety of SPD465 in Treating Adults With ADHD. (NCT00152035) | Shire | 2005-03-10 |
| A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. (NCT00246220) | Janssen Pharmaceutica N.V., Belgium | 2005-03-01 |
| Long-Duration Stimulant Treatment Study of ADHD in Young Children (NCT00257725) | New York State Psychiatric Institute | 2005-03-01 |
| CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults (NCT00246207) | Janssen-Ortho Inc., Canada | 2005-03-01 |
| Brain Changes in Children and Adolescents With Behavioral Problems (NCT00104039) | National Institute of Mental Health (NIMH) | 2005-02-17 |
| Efficacy and Safety of SPD465 in Adults With ADHD (NCT00150579) | Shire | 2005-01-27 |
| A Clinic-based Prevention Program for Families of Depressed Mothers (NCT00149812) | Johns Hopkins Bloomberg School of Public Health | 2005-01-01 |
| Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar (NCT00174226) | Pfizer | 2004-11-01 |
| Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials (NCT00151957) | Noven Therapeutics | 2004-10-01 |
| NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD (NCT00557011) | New River Pharmaceuticals | 2004-09-01 |
| Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder (NCT00118911) | Massachusetts General Hospital | 2004-09-01 |
| Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00151996) | Shire | 2004-08-16 |
| Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD (NCT00466791) | Noven Therapeutics | 2004-08-01 |
| Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (NCT00386581) | Eli Lilly and Company | 2004-07-01 |
| Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) (NCT00218543) | New York State Psychiatric Institute | 2004-06-01 |
| Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 (NCT00150618) | Shire | 2004-03-30 |
| ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD (NCT00557960) | Shire | 2004-02-25 |
| Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior. (NCT00550147) | Indiana University | 2004-02-01 |
| Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder (NCT00228046) | Stony Brook University | 2004-01-01 |
| A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder (NCT00190931) | Eli Lilly and Company | 2003-11-01 |
| Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings (NCT00179894) | Ann & Robert H Lurie Children's Hospital of Chicago | 2003-06-01 |
| Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 (NCT00152009) | Shire | 2003-01-29 |
| Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I (NCT00071656) | University of California, San Francisco | 2002-09-01 |
| Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder (NCT02951754) | Hospital de Clinicas de Porto Alegre | 2002-02-01 |
| Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders (NCT00025779) | National Institute of Mental Health (NIMH) | 2001-10-01 |
| Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder (NCT00050050) | Massachusetts General Hospital | 2001-09-01 |
| Preventing Behavior Problems in Children With ADHD (NCT00057668) | Lehigh University | 2001-09-01 |
| Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) (NCT00050622) | Florida International University | 2001-09-01 |
| Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) (NCT00018863) | New York State Psychiatric Institute | 2001-04-01 |
| Brain Imaging in Children With AD/HD (NCT00008892) | National Institute of Mental Health (NIMH) | 2001-01-12 |
| Methylphenidate for Treating Children With ADHD and Tourette Syndrome (NCT00441649) | Stony Brook University | 2000-02-01 |
| Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children (NCT00031395) | University of Cincinnati | 1999-09-01 |
| Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation (NCT00001915) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-01-01 |
| Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) (NCT00000388) | NYU Langone Health | 1998-09-01 |
| Methylphenidate Treatment for Cocaine Abuse and ADHD - 1 (NCT00136734) | New York State Psychiatric Institute | 1998-04-01 |
| Genetic Aspects of Neurologic and Psychiatric Disorders (NCT00001544) | National Institute of Mental Health (NIMH) | 1996-04-01 |
| Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers (NCT00001246) | National Institute of Mental Health (NIMH) | 1990-06-19 |
| Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) (NCT00001206) | National Institute of Mental Health (NIMH) | 1985-06-05 |
| Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder (NCT00011466) | National Center for Research Resources (NCRR) | |
| Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS) (NCT00460720) | Johnson & Johnson Taiwan Ltd | |